What is IGC Pharma, Inc.'s Market Cap?

IGC Pharma, Inc.'s Market Cap is $30.0M, based on as-reported figures from SEC (XBRL) filings.

What is IGC Pharma, Inc.'s Enterprise Value?

IGC Pharma, Inc.'s Enterprise Value is $29.0M, based on as-reported figures from SEC (XBRL) filings.

What is IGC Pharma, Inc.'s Price / Sales?

IGC Pharma, Inc.'s Price / Sales is 27.1×, based on as-reported figures from SEC (XBRL) filings.

What is IGC Pharma, Inc.'s EV / Revenue?

IGC Pharma, Inc.'s EV / Revenue is 26.2×, based on as-reported figures from SEC (XBRL) filings.

What is IGC Pharma, Inc.'s EV / EBITDA?

IGC Pharma, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is IGC Pharma, Inc.'s Revenue (TTM)?

IGC Pharma, Inc.'s Revenue (TTM) is $1.1M, based on as-reported figures from SEC (XBRL) filings.

What is IGC Pharma, Inc.'s Net Income (TTM)?

IGC Pharma, Inc.'s Net Income (TTM) is -$6.4M, based on as-reported figures from SEC (XBRL) filings.

What is IGC Pharma, Inc.'s EBITDA?

IGC Pharma, Inc.'s EBITDA is -$7.5M, based on as-reported figures from SEC (XBRL) filings.

What is IGC Pharma, Inc.'s Diluted EPS (TTM)?

IGC Pharma, Inc.'s Diluted EPS (TTM) is -0.06, based on as-reported figures from SEC (XBRL) filings.

What is IGC Pharma, Inc.'s EBITDA Margin?

IGC Pharma, Inc.'s EBITDA Margin is -680.2%, based on as-reported figures from SEC (XBRL) filings.

IGC Pharma, Inc. (IGC) Financial Statements

IGC Pharma, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SQQKX0

XASE · usd

0.29▲ 0.00 (0.00%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close0.29

Day's Range0.29 – 0.30

52-Week Range0.24 – 0.45

Volume558.8K

Avg Volume871.0K

Share Statistics

Shares Outstanding

Employees70

ExchangeXASE

Listed2006-04-13

Share count as of August 5, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about IGC Pharma, Inc. (IGC)

What is IGC Pharma, Inc.'s Market Cap?: IGC Pharma, Inc.'s Market Cap is $30.0M, based on as-reported figures from SEC (XBRL) filings.
What is IGC Pharma, Inc.'s Enterprise Value?: IGC Pharma, Inc.'s Enterprise Value is $29.0M, based on as-reported figures from SEC (XBRL) filings.
What is IGC Pharma, Inc.'s Price / Sales?: IGC Pharma, Inc.'s Price / Sales is 27.1×, based on as-reported figures from SEC (XBRL) filings.
What is IGC Pharma, Inc.'s EV / Revenue?: IGC Pharma, Inc.'s EV / Revenue is 26.2×, based on as-reported figures from SEC (XBRL) filings.
What is IGC Pharma, Inc.'s EV / EBITDA?: IGC Pharma, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is IGC Pharma, Inc.'s Revenue (TTM)?: IGC Pharma, Inc.'s Revenue (TTM) is $1.1M, based on as-reported figures from SEC (XBRL) filings.
What is IGC Pharma, Inc.'s Net Income (TTM)?: IGC Pharma, Inc.'s Net Income (TTM) is -$6.4M, based on as-reported figures from SEC (XBRL) filings.
What is IGC Pharma, Inc.'s EBITDA?: IGC Pharma, Inc.'s EBITDA is -$7.5M, based on as-reported figures from SEC (XBRL) filings.
What is IGC Pharma, Inc.'s Diluted EPS (TTM)?: IGC Pharma, Inc.'s Diluted EPS (TTM) is -0.06, based on as-reported figures from SEC (XBRL) filings.
What is IGC Pharma, Inc.'s EBITDA Margin?: IGC Pharma, Inc.'s EBITDA Margin is -680.2%, based on as-reported figures from SEC (XBRL) filings.